Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model. - Wikidata - awgldk - TriplyDB

Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model.

Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model.

http://www.wikidata.org/entity/Q37455627

about

Treatment of medulloblastoma with a modified measles virus Biosafety considerations for attenuated measles virus vectors used in virotherapy and vaccination Stem Cell-Based Cell Carrier for Targeted Oncolytic Virotherapy: Translational Opportunity and Open Questions Patient-derived mesenchymal stem cells as delivery vehicles for oncolytic virotherapy: novel state-of-the-art technology Cancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Mesenchymal stem cells as a vector for the inflammatory prostate microenvironment Measles to the Rescue: A Review of Oncolytic Measles Virus Oncolytic Adenovirus-Loaded Menstrual Blood Stem Cells Overcome the Blockade of Viral Activity Exerted by Ovarian Cancer Ascites The use of neural stem cells in cancer gene therapy: predicting the path to the clinic.Oncolytic Viruses to Treat Ovarian Cancer Patients - a Review of Results From Clinical Trials Close interactions between mesenchymal stem cells and neuroblastoma cell lines lead to tumor growth inhibition.Carrier cell-based delivery of replication-competent HSV-1 mutants enhances antitumor effect for ovarian cancer.Lymphokine-activated killer and dendritic cell carriage enhances oncolytic reovirus therapy for ovarian cancer by overcoming antibody neutralization in ascites Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth.Oncolytic measles virus expressing the sodium iodide symporter to treat drug-resistant ovarian cancer.A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma Envelope-chimeric entry-targeted measles virus escapes neutralization and achieves oncolysis.Molecular imaging for assessment of mesenchymal stem cells mediated breast cancer therapy Oncolytic virotherapy for ovarian cancer.Polyinosinic acid decreases sequestration and improves systemic therapy of measles virus.Attenuated oncolytic measles virus strains as cancer therapeutics Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastoma A specific subpopulation of mesenchymal stromal cell carriers overrides melanoma resistance to an oncolytic adenovirus Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumors Polymeric oncolytic adenovirus for cancer gene therapy.MMP14 as a novel downstream target of VEGFR2 in migratory glioma-tropic neural stem cells.Optimizing patient derived mesenchymal stem cells as virus carriers for a phase I clinical trial in ovarian cancer.Assessment of current virotherapeutic application schemes: "hit hard and early" versus "killing softly"?Enhancing cytokine-induced killer cell therapy of multiple myeloma.To grab the stroma by the horns: from biology to cancer therapy with mesenchymal stem cells Oncolytic measles virus strains as novel anticancer agents.A novel, polymer-coated oncolytic measles virus overcomes immune suppression and induces robust antitumor activity.Oncolytic vaccinia virotherapy for endometrial cancer Crossing the boundaries: stem cells and gene therapy.New perspectives in cancer virotherapy: bringing the immune system into play.Use of attenuated paramyxoviruses for cancer therapy.Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?Recent advances in oncolytic virus design.Oncolytic Newcastle disease virus for cancer therapy: old challenges and new directions.Oncolytic virotherapy

P2860

Q24602003-DD91E72E-776B-43A3-B620-2A62177D3AB7 Q26700080-2203535D-BED5-4DBC-BE03-9CB186CFF400 Q26775038-32DAC087-F99A-431F-B626-B47342DAD762 Q26821929-EA58793F-D1DA-4066-A8EC-5EE82EC57C21 Q26830028-2436B912-B293-47E3-B2AC-6C9AD475C69A Q26853374-5533005F-3ED8-45EA-8780-F9080D52FA55 Q28072097-4D3BE045-2072-42CC-A061-636FAC9D70EC Q33904378-FDA98651-4B80-4118-A43E-FFBE4548402B Q34217778-DF55A456-9FDD-4DEE-A9E0-006FD3DCE871 Q34432804-BD9FE6F2-CFF9-4C84-9A42-17D432403F82 Q34465378-3D60D0F0-17E9-4AC6-BC0A-F1BA95A6C693 Q34512446-D0907243-5933-489F-B57C-A291BA9734DB Q35061974-9C6899BD-8386-4330-9085-047ED9A753BA Q35073868-9953480E-BC85-4B90-B20B-73AC2A9EA635 Q35226511-4EE85598-473F-4877-8445-AFF9E8E4326E Q35256949-B73FAF93-180D-42F6-9333-11D2EFFB5B49 Q35285887-C4CECBA1-2149-498E-B9C0-23DC61631235 Q35553117-371F1427-CEBC-4269-AB4A-1D7BA774594E Q35597082-760A52C5-5C4B-4EDA-84F7-C21582F9E4DC Q35785494-12121C57-7D12-4433-92C1-6A2C05D65493 Q35818876-9334F191-593D-4444-A7E7-14C6307B6FDE Q35845219-1A15A8A4-5310-486E-9FCF-66C9665B2477 Q36225368-50A00447-941F-46D5-822A-946FEFB3A1EA Q36250723-301BEB4B-CD46-4A77-A0FE-5B3D4B3469CD Q36344901-B710472F-74A1-46BD-9AA8-AB2D7ECB60D9 Q36421256-D801620F-14EC-44D5-8052-36DB6CC73A2A Q36597119-0B4A00C6-1E9B-44FC-9EF3-FF72ABDC25E5 Q36664268-580B044A-45E8-46A4-8BE1-41B596D1FAFD Q36892290-F4F5091E-FB17-46C2-AFD2-2A327FA173B8 Q37093530-3252DF61-A8B8-48A4-88DB-6A74BD152D36 Q37261017-46840BD6-522D-4755-ACA8-C47B2341EE80 Q37388411-F01FD50A-3E7B-4893-9BB1-79FE29322A09 Q37688850-4AC29E2B-64F7-40A8-9390-05F0776A41CD Q37720803-4579BF9A-424C-4B4C-B239-5F8663ECE71E Q37773253-74C13700-0DFE-4D6F-8A8E-7A665C7AD08F Q37810599-39688D72-9789-4182-AB8D-FC74EEDD8F61 Q37833578-056045D8-B04C-44E7-ABA3-E92968D6432A Q37865172-EF764A16-16DF-4C8A-9EF2-7D7695D7D7A2 Q37990940-7645C080-51CC-4103-AF02-3BE81426BF57 Q38025263-075ECFFF-1684-44FE-A585-0B41D89B3816

P2860

Mesenchymal stem cell carriers protect oncolytic measles viruses from antibody neutralization in an orthotopic ovarian cancer therapy model.

http://www.wikidata.org/entity/Q37455627

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年学术文章

@wuu

2009年学术文章

@zh-cn

2009年学术文章

@zh-hans

2009年学术文章

@zh-my

2009年学术文章

@zh-sg

2009年學術文章

@yue

2009年學術文章

@zh

2009年學術文章

@zh-hant

name

Mesenchymal stem cell carriers ...... ovarian cancer therapy model.

@en

Mesenchymal stem cell carriers ...... ovarian cancer therapy model.

@en-gb

Mesenchymal stem cell carriers ...... ovarian cancer therapy model.

@nl

type

label

Mesenchymal stem cell carriers ...... ovarian cancer therapy model.

@en

Mesenchymal stem cell carriers ...... ovarian cancer therapy model.

@en-gb

Mesenchymal stem cell carriers ...... ovarian cancer therapy model.

@nl

prefLabel

Mesenchymal stem cell carriers ...... ovarian cancer therapy model.

@en

Mesenchymal stem cell carriers ...... ovarian cancer therapy model.

@en-gb

Mesenchymal stem cell carriers ...... ovarian cancer therapy model.

@nl

P1433

Q37455627-63DD43E9-A6D3-49FD-8645-1D54DAB9D066

P1476

Q37455627-977EF2AC-E6A6-439F-9E1A-E2A421808645

P2093

Q37455627-16EE4315-6B18-45DC-A7D8-A5BCEF85908A

Q37455627-2BB8ACB8-F47C-4797-B5A1-0CA6EF09675C

Q37455627-2E5CEA08-6376-4651-86E0-14EE801A71CC

Q37455627-5F4EF703-FE03-4C14-B585-54E952FBBD48

Q37455627-ADC64099-B4B8-44DC-B27C-15C1FF3AB341

Q37455627-D99F35A1-75CA-4D2C-B92A-F551E408F047

P2860

Q37455627-003A81A9-965C-4034-9E12-9A1F0731B949

Q37455627-05D5A693-5F4D-4F07-91FF-9637E8F6268D

Q37455627-15B7E794-04CB-4065-AB6A-AC33D30BB6C8

Q37455627-18643DD7-80F3-4714-8736-F328EEB07F7B

Q37455627-1B151346-8984-4FA7-877B-C7D634592FF3

Q37455627-1E2B19E0-BB91-4820-A471-947031ACE5C7

Q37455627-2530DDFA-B8FF-4F40-B910-48282C3F4F76

Q37455627-2AB62F4D-15F5-464E-8799-CCDB2CE9704E

Q37455627-3075122A-E504-49EA-8CC2-6092CCC74438

Q37455627-4583700C-D171-4E65-B5E9-A5457611249B

P304

Q37455627-DB5FCABA-CEF0-4362-B3DB-0BF02E4A485F

P31

Q37455627-D78BC2DB-D691-434E-B092-D367B75E3C58

P356

Q37455627-DB6E961E-8A43-4F7C-8A10-D217D1971E37

P407

Q37455627-868175AD-11EE-4040-8BD2-88E31BC61A6E

P433

Q37455627-A138DF1D-F016-4DB6-B98F-A81049C14C58

P478

Q37455627-AF11EA12-CF25-4B84-A47B-85F7E2C4E5DF

P50

Q37455627-4E193D70-3E87-45C6-9036-4780DE572502

Q37455627-7312FA7A-3DC5-40C0-82C5-7A5DA4ACBE53

Q37455627-8126850D-F30B-462E-A2F1-7D0D9F79D0E8

P577

Q37455627-19A05DA9-6576-4614-AA17-7515DB39EC93

P698

Q37455627-66419A4B-1DA9-4A4D-A567-A31025BC9612

P921

Q37455627-AF32E449-F70B-4627-95A8-4668134FBF1D

Q37455627-C1DEEBFF-3A8F-457B-954C-1BD2DC5FFC29

Q37455627-DB501AE0-95E5-4EB7-B98B-3C1467B15AF6

Q37455627-ECBE03F6-1B5F-4A83-87E2-6AAEB0F667BB

P932

Q37455627-3A23AAF5-EE2E-40AD-B1CB-6C1B821D2C99

P356

1078-0432.CCR-09-1292

P1433

Clinical Cancer Research

P1476

Mesenchymal stem cell carriers ...... ovarian cancer therapy model.

@en

P2093

Allan B Dietz

http://www.w3.org/2001/XMLSchema#string

Emily K Mader

http://www.w3.org/2001/XMLSchema#string

Greg W Butler

http://www.w3.org/2001/XMLSchema#string

Holly M Russell

http://www.w3.org/2001/XMLSchema#string

Yi Lin

http://www.w3.org/2001/XMLSchema#string

Yoshihiro Maeyama

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2008

Optimal chemotherapy treatment for women with recurrent ovarian cancer

Tumor-associated macrophages infiltrate plasmacytomas and can serve as cell carriers for oncolytic measles virotherapy of disseminated myeloma.

Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter.

Mutant torsinA interferes with protein processing through the secretory pathway in DYT1 dystonia cells.

Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses

Targeted gene therapy for ovarian cancer.

Novel therapeutic agents in ovarian cancer.

From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells.

Cell-based delivery of oncolytic viruses: a new strategic alliance for a biological strike against cancer.

P304

7246-7255

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-09-1292

http://www.w3.org/2001/XMLSchema#string

P407

P433

23

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

Stephen J Russell

Evanthia Galanis

P577

2009-11-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19934299

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

2787715

http://www.w3.org/2001/XMLSchema#string